Questions About Cancer? 1-800-4-CANCER

All News Releases

MIT researchers find that a nanodevice could defeat drug resistance
NCI Cancer Center News
(Posted: 03/03/2015) - A nanodevice, which consists of gold nanoparticles embedded in a hydrogel that can be injected or implanted at a tumor site, could also be used more broadly to disrupt any gene involved in cancer.

MD Anderson study shows why some brain cancers resist treatment
NCI Cancer Center News
(Posted: 03/03/2015) - Scientists at The University of Texas MD Anderson Cancer Center may have discovered why some brain cancer patients develop resistance to standard treatments including radiation and the chemotherapy agent temozolomide.

Dana-Farber researchers develop precision medicine tool that could help personalize cancer treatments
NCI Cancer Center News
(Posted: 02/27/2015) - A new laboratory test predicts which of several cancer drugs will work best against a patient's tumor, and could become a precision medicine tool for individualizing cancer therapy.

Indiana U researchers identify pancreatic cancer patients who may benefit from personalized treatment
NCI Cancer Center News
(Posted: 02/27/2015) - Cancer researchers at Indiana University report that about 15 percent of people with pancreatic cancer may benefit from therapy targeting a newly identified gene signature.

St. Jude researchers find that an inherited gene variation leaves young leukemia patients at risk for peripheral neuropathy
NCI Cancer Center News
(Posted: 02/25/2015) - Research led by St. Jude Children’s Research Hospital investigators could help reduce side effects associated with the anti-cancer drug vincristine, which is widely used to treat cancer in children and adults.

U of Colorado researchers find that even low-androgen triple-negative breast cancer responds to anti-androgen therapy
NCI Cancer Center News
(Posted: 02/25/2015) - Clinical trials are underway of anti-androgen drugs against high-androgen triple-negative breast cancers, and new work from the University of Colorado Cancer Center shows the threshold for benefit from anti-androgen therapies may be much lower than previously thought.

MD Anderson studies skin cancer patients resistant to therapy
NCI Cancer Center News
(Posted: 02/24/2015) - Researchers may have found a way to more accurately predict which patients will likely respond to genomic-based follow-up therapies, by looking at unique protein patterns in melanoma patients.

Columbia U researchers find that disparities in breast cancer care are linked to net worth
NCI Cancer Center News
(Posted: 02/24/2015) - Household net worth is a major and overlooked factor in adherence to hormonal therapy among breast cancer patients and partially explains racial disparities in quality of care.

Stanford study finds that customized DNA rings aid early cancer detection in mice
NCI Cancer Center News
(Posted: 02/24/2015) - Tiny DNA rings, carrying instructions for making a blood-detectable biomarker, can enter both healthy cells and cancer cells.

Moffitt researchers participate in HPV international phase 2/3 trial
NCI Cancer Center News
(Posted: 02/23/2015) - A pivotal international phase 2/3 clinical trial involving Moffitt Cancer Center faculty demonstrated that vaccination with Gardasil 9 protects against nine HPV types, seven of which cause most cases of cervical, vulvar, and vaginal disease.

< Previous  1 2 3 4 5 6 7 8 9 10 11 12 13  Next >